Skip to main content

Edgestream Partners, L.P.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1535061 Princeton, NJ

Position in REGN

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$2,655,033
-$888,622 QoQ
Shares Held
4,258
-7.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#480
of 1,322 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Edgestream Partners, L.P. holds $89,105,792 across 25 Biotechnology names. REGN ranks #15 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,655,033 4,258
2025-12-31 $3,543,655 4,591
2025-09-30 $4,995,768 8,885
2025-06-30 $5,445,825 10,373
2025-03-31 $1,426,383 2,249
2024-12-31 $6,284,175 8,822
2024-09-30 $364,780 347
2024-06-30 $5,483,223 5,217
2024-03-31 $7,352,461 7,639
2023-09-30 $1,067,379 1,297
2023-06-30 $603,573 840
2022-12-31 $212,839 295
2022-09-30 $4,578,230 6,646
2022-06-30 $2,654,764 4,491
2022-03-31 $2,567,391 3,676
2021-09-30 $961,025 1,588
2020-09-30 $2,666,791 4,764